RecruitingPhase 4NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
Sponsor: Bristol-Myers Squibb
Austin, TX · DeSoto, TX · +14 more sites
Schizophrenia clinical trials in Austin, TX
15 recruiting schizophrenia studies with a site in Austin, TX.
RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Austin, TX · DeSoto, TX · Houston, TX · +42 more sites
RecruitingPhase 2NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Sponsor: MapLight Therapeutics
Austin, TX · McKinney, TX · Sugarland, TX · +34 more sites
RecruitingPhase 1NCT07615426
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Sponsor: Janssen Research & Development, LLC
Austin, TX · Richardson, TX · +6 more sites
RecruitingPhase 3NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Austin, TX · Dallas, TX · Richardson, TX · +31 more sites
RecruitingPhase 3NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Austin, TX · DeSoto, TX · Houston, TX · +47 more sites
RecruitingPhase 3NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Austin, TX · Dallas, TX · DeSoto, TX · +99 more sites
RecruitingPhase 4NCT07105111
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Sponsor: Neurocrine Biosciences
Austin, TX · +18 more sites
RecruitingPhase 2NCT07145918
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Sponsor: AbbVie
Austin, TX · Richardson, TX · +5 more sites
RecruitingPhase 1NCT07061288
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Sponsor: Bristol-Myers Squibb
Austin, TX · +7 more sites
RecruitingPhase not listedNCT07379827
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Sponsor: Bristol-Myers Squibb
Austin, TX · Dallas, TX · Fort Worth, TX · +52 more sites
RecruitingPhase 2NCT07191483
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Sponsor: Kynexis B.V.
Austin, TX · +14 more sites
RecruitingPhase 3NCT06963034
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Austin, TX · DeSoto, TX · Houston, TX · +18 more sites
RecruitingPhase 3NCT06961968
Randomized Withdrawal Study in Patients With Schizophrenia
Sponsor: Vanda Pharmaceuticals
Austin, TX · Houston, TX · Irving, TX · +19 more sites
RecruitingPhase 3NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor: Reviva Pharmaceuticals
Austin, TX · Richardson, TX · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.